Reuters AlertNet Full site
Homepage | Newsdesk | NGO Latest | Crisis briefings | Country profiles | MediaWatch | Jobs | Alerting | Login

NEWSDESK

GLOBAL: Clinton Foundation closes deal to slash cost of second-line ARVs
07 Aug 2009 16:22:31 GMT
 Source: IRIN

Background

•  AIDS in Africa

•  AIDS pandemic

•  Health and diseases

MORE >>
NAIROBI, 7 August 2009 (IRIN) - The Clinton Foundation has announced agreements with two drug companies to bring the cost of second-line antiretrovirals (ARVs) to under US$500 per person annually and reduce the cost of a key tuberculosis (TB) drug to $1 per dose.

"Today's announcement will help ensure we can sustain treatment over a lifetime, and better treat patients with both HIV and TB, two key steps in turning the tide of the global HIV/AIDS pandemic," former United States President Bill Clinton said at the Foundation's headquarters in New York.

Starting in 2010, pharmaceutical company Mylan and its subsidiary, Matrix, will make available four second-line drugs – atazanavir, ritonavir, tenofovir and lamivudine – at a cost of $425 per person per year.

Matrix's new product will allow patients to take three pills once a day instead of five or more pills twice a day. The product will also include the first ever version of ritonavir that does not require continuous refrigeration, making transport and distribution in developing countries much easier.

Pfizer pharmaceuticals will reduce the price by 60 percent and expand the availability of rifabutin, which is used to treat TB in patients taking second-line ARVs. TB is the leading cause of death among people living with HIV.

"At the moment, second-line ARVs in Kenya cost $1,000 per person per year, while first-line ARVs cost under $100," said James Kamau, coordinator of the Kenya Treatment Access Movement, who has been on first-line ARVs for the past eight years.

"Even if 10 percent of the 260,000 people on ARVs needed second-line drugs today, it would cost more to put them on second-line drugs than all those on first-line ARVs."

He said the lower cost of second-line drugs would save countless lives, and "This price reduction is therefore fantastic news."

In 2008 the UN World Health Organization estimated that only about two percent of patients in low- and middle-income countries were on second-line ARVs, but the number was rising because every year about three percent of ARV patients switched from first- to second-line treatment.

kr/kn/he

© IRIN. All rights reserved. More humanitarian news and analysis: http://www.IRINnews.org


AlertNet news is provided by
Email this article       Send comments

Emergencies

•  AIDS in Africa

•  AIDS pandemic

MORE >>

NGO latest

•  Kenya food crisis: urgent funding needed in Turkana
Merlin - UK

•  Merlin welcomes fresh expertise to Board of Trustees
Merlin - UK

•  Climate Change & Health
Health Unlimited

•  Romanian priests learn to fight against HIV-related stigma & discrimination
World Vision Middle East/Eastern Europe/ Central Asia

•  Drought Threatens Millions of East Africans, LWR is Responding
LWR - USA

MORE >>

Latest news

•  GLOBAL: Clinton Foundation closes deal to slash cost of second-line ARVs

•  INTERVIEW-Somali president calls for help vs militants

•  Global Fund grants Zimbabwe $37.9 mln to fight AIDS

•  INTERVIEW-Somali president calls for help to combat militants

•  ETHIOPIA: Government empowers nurses to boost ARV treatment

MORE >>

IRIN news

Background information

Briefings
AIDS in Africa - [Who works where]
AIDS pandemic - [Who works where]

Facts & figures
Kenya

Related articles

Breaking stories
 GLOBAL: Clinton Foundation closes deal to slash cost of second-line ARVs (1 minute ago)

INTERVIEW-Somali president calls for help vs militants (1 minute ago)

AlertNet insight
 Wounds fester a year after Kenya election violence (1 minute ago)

Aid agency news feed
 Kenya food crisis: urgent funding needed in Turkana (1 minute ago)

Blogs
 Climate talks need a dose of top-level political will (1 minute ago)

Maps
 Dadaab Refugee Camps – Overview, Garissa, N.Eastern, Kenya (1 minute ago)


Del.icio.us Del.icio.us  |   Digg Digg  |   NewsVine NewsVine  |   Reddit Reddit   
Thumb for /thefacts/imagerepository/RTRPICT/2009-08-06T182149Z_01_NYK713D_RTRIDSP_2_KOREA-NORTH-USA-CLINTON_mainimage.jpg|/thenews/pictures/NYK713D.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-08-06T181306Z_01_NYK712D_RTRIDSP_2_KOREA-NORTH-USA-CLINTON_mainimage.jpg|/thenews/pictures/NYK712D.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-08-06T181126Z_01_NYK711D_RTRIDSP_2_KOREA-NORTH-USA-CLINTON_mainimage.jpg|/thenews/pictures/NYK711D.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-08-06T180102Z_01_NYK709D_RTRIDSP_2_KOREA-NORTH-USA-CLINTON_mainimage.jpg|/thenews/pictures/NYK709D.htm
Thumb for /thefacts/imagerepository/RTRPICT/2009-08-06T180006Z_01_NYK708D_RTRIDSP_2_KOREA-NORTH-USA-CLINTON_mainimage.jpg|/thenews/pictures/NYK708D.htm

Former U.S. President Bill Clinton (R) speaks at a news conference with Robert J. Coury, Chairman and Chief Executive of Mylan (L) and Jeffrey B. Kindler, Chairman and Chief Executive of ...


More pictures | Galleries
Disclaimers |  Copyright |  Privacy |  Contact Us |  Feedback |  About Us |  RSS XML

Last updated:Fri Aug 7 16:22:59 2009